Management of benign prostate hyperplasia (BPH) by combinatorial approach using alpha-1-adrenergic antagonists and 5-alpha-reductase inhibitors-Reference-Cited by-同舟云学术

Management of benign prostate hyperplasia (BPH) by combinatorial approach using alpha-1-adrenergic antagonists and 5-alpha-reductase inhibitors

Published:2020-09 Issue: Volume:883 Page:173301
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Zitoun Osama A.^ORCID,Farhat Abdulrahman MN.^ORCID,Mohamed Mohamed A.^ORCID,Hamad Mohammad R.^ORCID,Aramini Beatrice^ORCID,Haider Khawaja Husnain^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference76 articles.

1. Safety of anticholinergics in patients with benign prostatic hyperplasia;Athanasopoulos;Expet Opin. Drug Saf.,2008

2. The American urological association symptom index for benign prostatic hyperplasia. The measurement committee of the American urological association;Barry;J. Urol.,1992

3. Personalized medicine for the management of benign prostatic hyperplasia;Bechis;J. Urol.,2014

4. Association between tamsulosin and serious ophthalmic adverse events in older men following cataract surgery;Bell;JAMA, J. Am. Med. Assoc.,2009

5. The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis;Blake-James;BJU Int.,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update;Expert Opinion on Emerging Drugs;2024-06-14

2. Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: a systematic review and network meta-analysis;Scientific Reports;2024-05-15

3. The human microbiome and benign prostatic hyperplasia: Current understandings and clinical implications;Microbiological Research;2024-04

4. Omentin-1 inhibits the development of benign prostatic hyperplasia by attenuating local inflammation;Molecular Medicine;2024-03-22

5. Prostate diseases: pathogenetic bases and therapeutic possibilities of entomotherapy;Andrology and Genital Surgery;2022-09-09